Resources
- FDA Approves Iptacopan for the Treatment of PNH
- Cyclic Peptides: Current Status & Future Prospects
- FDA Approves SYFOVRE™ – First Treatment for Geographic Atrophy
- Nanobodies - Current Status and Prospects
- Targeted Therapies for Multiple Myeloma (MM)
- IL-6 Unveiled: From Inflammation to Breakthrough Therapeutics
- PEG‐rhG‐CSF for Neutropenia
- Emerging Multiple Myeloma Therapies: mAbs, ADCs, CAR-T Cells & Bispecific Antibodies
- GLP-1R Agonists for Weight Loss
- FDA Approves Tirzepatide, A Potential Blockbuster Drug for Type 2 Diabetes
